Trump GLP-1 Deal ‘Move in Right Direction’
Trump’s deal with drug manufacturers lowering the cost of GLP-1s will expand coverage for many patients. Caroline Messer, MD, explains why she welcomes this deal. Medscape Gastroenterology
WHO backs use of GLP-1 drugs for weight loss, along with diet, exercise
WHO guidelines say GLP-1 drugs are effective as long-term treatment for obesity in adults, barring pregnant women, alongside diet, exercise interventions; call for equitable access to reduce global obesity costs
WHO: Long-Term GLP-1 Therapies Recommended for Adults With Obesity
TUESDAY, Dec. 2, 2025 — Long-term glucagon-like peptide-1 (GLP-1) therapies combined with intensive behavioral therapy are recommended for adults with obesity, according to a special communication from the World Health Organization published…
Fractyl Health says procedure can maintain weight loss after stopping GLP-1
Brainstem GLP-1 neurons modulate physiological satiation and drive sustained weight loss in obese mice
Glucagon-like peptide-1 receptor (GLP-1R) activation in the brain strongly reduces appetite, but most brain GLP-1Rs are not accessible for systemically administered GLP-1R agonists. Acute activation of nucleus tractus solitarius (NTS) GLP-1 neurons, targeting brain GLP-1Rs, strongly suppresses food intake separate from GLP-1R agonists. However, it is unknown if their chronic stimulation is a viable strategy […]
Will blockbuster obesity drugs revolutionize addiction treatment?
Nature, Published online: 02 December 2025; doi:10.1038/d41586-025-03911-x Scientists are testing whether GLP-1 drugs can help to cut cravings for cigarettes, alcohol and opioids — as well as food.
Could Weight Loss Drugs Turn Fat Cats Into Svelte Ozempets?
GLP-1 drugs for pets could be the next frontier for the blockbuster weight loss and diabetes drugs.
Obesities, Vol. 5, Pages 88: Nutritional Approaches to Enhance GLP-1 Analogue Therapy in Obesity: A Narrative Review
Obesities, Vol. 5, Pages 88: Nutritional Approaches to Enhance GLP-1 Analogue Therapy in Obesity: A Narrative Review Obesities doi: 10.3390/obesities5040088 Authors: Denise Deo Dias Andrea Rodrigues Vasconcelos Ana Carolina Remondi Souza Caroline de Menezes Isabella Sobral Teixeira e Silva José João Name Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are highly effective in the management of obesity; […]
Metropolis launches GLP-1 monitoring test packages, targets obesity market
Metropolis Healthcare has rolled out three TruHealth GLP-1 test packages for patients preparing for or undergoing obesity treatment, as diagnostics firms move to tap the fast-growing segment
UPSC Key: Sanchar Saathi app, GPS ‘spoofing’, and WHO guidelines on use of GLP-1
Post Content